Concepedia

Kristine A. Isanogle

KA

Statistics

Publications

5

Citations

226

H-Index

5

Active since

2018

Affiliations

National Cancer Institute(Current)

National Center for Advancing Translational Sciences

Frederick National Laboratory for Cancer Research

Center for Cancer Research

National Institutes of Health

Kristine A. Isanogle is an author at National Cancer Institute specializing in cancer therapeutics, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2018–2023

5

Publications

5

MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma

Marielle E. Yohe, Berkley E. Gryder, Jack F. Shern et al. · Science Translational Medicine · 2018 · 146 citations · Full text

Aging and CNS Myeloid Cell Depletion Attenuate Breast Cancer Brain Metastasis

Alex Man Lai Wu, Selamawit Gossa, Ramakrishna Samala et al. · Clinical Cancer Research · 2021 · 29 citations · Full text

Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

Joshua T. Kowalczyk, Xiaolin Wan, Edjay R. Hernandez et al. · Molecular Cancer Therapeutics · 2020 · 20 citations · Full text

, , +16

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Katie E. Hebron, Xiaolin Wan, Jacob S. Roth et al. · Clinical Cancer Research · 2022 · 20 citations · Full text

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma

Jerry T. Wu, Adam Cheuk, Kristine A. Isanogle et al. · Cancers · 2023 · 11 citations · Full text

1–5 of 5